Insider Trading History of Diamandis Peter

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Diamandis Peter since 2014. This trader's CIK number is 1528288. At the time of last reporting, Diamandis Peter was the Director of Vaxxinity, Inc.. (stock ticker symbol VAXX). Also see all insider trading activities at Vaxxinity, Inc..

Note that in the past Diamandis Peter also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Vaxxinity, Inc. (VAXX) by Diamandis Peter

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 VAXX 0 $0 0 $0 475,537 $423,227
2022 VAXX 0 $0 0 $0 652,764 $2,688,734
2021 VAXX 76,923 $0 0 $0 0 $0

Yearly summary of insider trading at Medavail Holdings, Inc. (MYOS) by Diamandis Peter

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 MYOS 3,444 $49,972 0 $0 0 $0

Yearly summary of insider trading at Celularity Inc (CELU) by Diamandis Peter

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 CELU 0 $0 0 $0 1,071,000 $299,880


Insider trading activities at 3 companies by Diamandis Peter:

1. Vaxxinity, Inc. (VAXX)

2. Medavail Holdings, Inc. (MYOS)

3. Celularity Inc (CELU)

Table 1. Insider trading of Vaxxinity, Inc. (VAXX) by Diamandis Peter

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-04-26 VAXX Option Ex 475,537 .89 423,227
2022-01-24 VAXX Option Ex 652,764 4.12 2,688,734
2021-11-15 VAXX Buy 76,923 .00 0

Table 2. Insider trading of Medavail Holdings, Inc. (MYOS) by Diamandis Peter

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-08-18 MYOS Buy 3,444 14.51 49,972

Table 3. Insider trading of Celularity Inc (CELU) by Diamandis Peter

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-02-10 CELU Option Ex 1,071,000 .28 299,880

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Diamandis Peter (Director of Vaxxinity, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.